Whole Body 3D Imaging

Designed specifically for dermatology, the VECTRA WB360 whole body 3D imaging system captures the entire exposed skin surface in macro quality resolution with a single capture. The fully integrated software allows clinicians to map and monitor pigmented lesions and distributed diseases of the skin. Other applications include documenting psoriasis and vitiligo.

Product

The ground-breaking VECTRA WB360 instantaneously records the patient’s entire exposed skin surface and body shape with a single capture.

Ideal for documenting inflammatory and pigmentary disorders
Pigmented Lesions
Lymphedema Management
Plastic and Reconstructive Surgery
Psoriasis
Burn Management
Vitiligo
Neurofibromatosis
Pigmented Lesions
Burn Management
Psoriasis
Vitiligo
Lymphedema Management
Neurofibromatosis
Plastic and Reconstructive Surgery
Experience

With 46 stereo vision pods, VECTRA WB360 produces a single,
accurate high-resolution 3D image.

The 3D whole body image is readily shared across networks or the secure ViewMyConsult® patient portal. The WB360 uses both cross‑polarized and non‑polarized lighting, developed specifically for capturing photographs of the human body.

  • On-board proprietary LED flashes, tuned to whole body skin imaging
  • Patented 3D cross-polarized lighting improves lesion assessment
  • Simplified and standardized patient photography
  • Minimized photography time
  • Reduced patient anxiety
The
Image 1

Advanced Total Body Skin Surveillance

DermaGraphix body mapping solution enables simple but powerful review of both overview and dermoscopy images,facilitating efficient and effective lesion surveillance. Smart automation ensures standardization and reproducibility, Markerless Tracking allows clinicians to more easily compare timepoints, and guided follow-up yields efficiency and repeatability.

Ultra-high resolution 3D images reduce the amount of close-up images required.

All close-up images are tagged to a single 3D image, improving the ability to track lesions over time.

Image 1

Faster Reviews With Better Organized Data

DermaGraphix Dashboard organizes dermoscopy images for optimal review and assessment.

Lesion Tagging for Efficient Exams and Accurate Follow-Ups

All dermoscopic images associated with a lesion are linked to an automatically-generated unique number and tagged to the 3D body map for efficient exams and accurate, workflow guided follow-ups.

Image 1

Psoriasis Assessment Tool

Image 1

Affected surface area, erythema (redness), induration (thickness) and desquamation (scaling) are scored clinically for each body region to determine the whole-body severity score.

Incorporating automatic detection of affected skin, only VECTRA WB360 3D images can accurately display the affected body surface area. Useful for both clinical and research purposes.

DermaGraphix software is now integrated with EPIC and EMA.

ViewMyConsult®

ViewMyConsult empowers patients to check for changes between office visits. In the privacy of their own home,  your patient can access their overview and close-up images through a secure, HIPAA-compliant web portal with multi-factor authorization.

Image 1
Image 1

DERMOSCOPY REIMAGINED

Achieve consistent and standardized imaging, ensuring reliable documentation and precision in every capture.

  • Unrivaled image quality
  • Most efficient workflow
  • Sequential cross-polarized and non-polarized capture
  • Capture both clinical and dermoscopy images
  • Award winning design
VECTRA WB360s

VECTRA WB360

What Our

VECTRA WB360

  • CBS (TV) News New York Features Canfield’s Whole Body 3D System for Skin Screenings
    JULY 9, 2025READ MORE
  • "Remote evaluation of general skin diseases using three-dimensional total body photography: An observer agreement study" Featured in Journal of the American Academy of Dermatology
    JUNE 4, 2025READ MORE
  • Experience Canfield Scientific’s Latest Imaging Innovations at AAD Booth #1229!
    FEBRUARY 27, 2025READ MORE
  • Canfield Scientific s.r.l Hosting the 4th Dreamoscopy Course: Integrated Intelligence
    DECEMBER 5, 2024READ MORE